// App-Quantinova.ai

B-051 : Less Bleeding Associated with Apixaban versus Other Direct Acting Oral Anticoagulation in Solid Organ Transplant Recipients

Researchers

Presenter

  • M. Thornberg

Principal Investigators

  • J. Scheffert

  • D. Jennings

  • J. Hedvat

  • N. Lange

  • H. Robbins

  • D. Salerno

Medical Centers

  • NewYork-Presbyterian Hospital, Department of Pharmacy, New York, NY

  • Long Island University School of Pharmacy, Brooklyn, NY

  • Columbia University Medical Center, Department of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved